Health professionals’ preferences with the use of pegfilgrastim on-body injector at oncology centers in 8 cities in Colombia

BACKGROUND: Febrile neutropenia associated with some chemotherapy regimens can lead to potentially fatal complications and high health care costs. Administration of pegfilgrastim using an On-Body Injector (OBI) may be more convenient for cancer patients and physicians in countries with limited acces...

Descripción completa

Detalles Bibliográficos
Autores principales: Larrarte-González, María Alejandra, Pineda-Posada, Mariana, Gaitán, Álvaro Andrés, Amaya-Amaya, Jenny, Ojeda, Kelman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207821/
https://www.ncbi.nlm.nih.gov/pubmed/37221537
http://dx.doi.org/10.1186/s12913-023-09454-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207821/
https://www.ncbi.nlm.nih.gov/pubmed/37221537
http://dx.doi.org/10.1186/s12913-023-09454-z

Ejemplares similares